Advanced Enzyme Technologies Ltd (ADEN)

Currency in INR
282.95
+2.65(+0.95%)
Closed·
ADVENZYMES is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
280.50287.50
52 wk Range
246.80419.00
Key Statistics
Bid/Ask
281.80 / 282.90
Prev. Close
280.3
Open
280.5
Day's Range
280.5-287.5
52 wk Range
246.8-419
Volume
65.3K
Average Volume (3m)
250.2K
1-Year Change
-8.8434%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ADVENZYMES Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
370.00
Upside
+30.77%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Advanced Enzyme Technologies Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 370.00
(+30.77% Upside)

Advanced Enzyme Technologies Ltd Earnings Call Summary for Q2/2027

  • Advanced Enzyme Q2 revenue hit $2.0B, beating forecasts by 11.17%; EBITDA rose 20% YoY to INR 721M with margin expanding to 34%.
  • Stock fell 2.56% to $274.25 despite revenue beat, reflecting investor caution over U.S. market recovery timeline and forward visibility.
  • Management guides 10-15% long-term growth with 30-32% EBITDA margin for FY27; expects U.S. turnaround within 1-2 quarters.
  • Broad-based growth across human healthcare, animal healthcare, and bio-processing offset U.S. weakness; top 10 customer concentration eased to 26%.
  • FY27 CapEx guided at INR 123 crore; cash position at INR 610 crore post-buyback with consumer B2C business remaining long-term focus.
Last Updated: 03/11/2026, 13:56
Read Full Transcript

Earnings

Latest Release
Oct 31, 2026
EPS / Forecast
4.32 / --
Revenue / Forecast
2B / 1.8B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 15.28
Dividend Yield
0.48%
Industry Median 0.80%
Annualised payout
1.35
Paid annually
5-Years Growth
+42.83%
Growth Streak

ADVENZYMES Income Statement

Compare ADVENZYMES to Peers and Sector

Metrics to compare
ADVENZYMES
Peers
Sector
Relationship
P/E Ratio
18.2x25.8x3.8x
PEG Ratio
1.15−0.320.00
Price/Book
1.9x1.5x1.6x
Price / LTM Sales
4.0x1.4x1.1x
Upside (Analyst Target)
31.3%17.1%50.0%
Fair Value Upside
Unlock8.9%5.7%Unlock

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain, fungal proteases, and bacterial alpha amylase. It also provides probiotics for human and animal nutrition. In addition, the company offers enzymes and probiotics for fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, oils and fats processing, biofuels, and specialty applications. Further, it provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India.

Industry
Chemicals
Employees
409
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.39M3.92%1.23B
Other Institutional Investors
66.28M59.19%18.58B
Public Companies & Retail Investors
41.31M36.89%11.58B
Total
111.98M100.00%31.39B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
OrbiMed Advisors LLC12.06%13,509,5223,786,719
Orbimed Asia Partners III, L.P.12.06%13,509,5223,786,719

People Also Watch

459.55
GNFC
+1.72%
123.12
CNBK
+0.15%
1,083.00
TACN
-0.30%
3,876.90
TTEX
+0.57%

FAQ

What Is the Advanced Enzyme Tech (ADVENZYMES) Stock Price Today?

The Advanced Enzyme Tech stock price today is 282.95 INR.

What Stock Exchange Does Advanced Enzyme Tech Trade On?

Advanced Enzyme Tech is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Advanced Enzyme Tech?

The stock symbol for Advanced Enzyme Tech is "ADVENZYMES."

What Is the Advanced Enzyme Tech Market Cap?

As of today, Advanced Enzyme Tech market cap is 31.45B INR.

What Is Advanced Enzyme Tech's Earnings Per Share (TTM)?

The Advanced Enzyme Tech EPS (TTM) is 15.28.

From a Technical Analysis Perspective, Is ADVENZYMES a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Advanced Enzyme Tech Stock Split?

Advanced Enzyme Tech has split 1 times.

How Many Employees Does Advanced Enzyme Tech Have?

Advanced Enzyme Tech has 409 employees.

What is the current trading status of Advanced Enzyme Tech (ADVENZYMES)?

As of Nov 08, 2026, Advanced Enzyme Tech (ADVENZYMES) is trading at a price of 282.95 INR, with a previous close of 280.30 INR. The stock has fluctuated within a day range of 280.50 INR to 287.50 INR, while its 52-week range spans from 246.80 INR to 419.00 INR.

What Is Advanced Enzyme Tech (ADVENZYMES) Price Target According to Analysts?

The average 12-month price target for Advanced Enzyme Tech is 370.00 INR, with a high estimate of 370 INR and a low estimate of 370 INR. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +30.77% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.